XTX Topco Ltd Makes New Investment in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• XTX Topco Ltd invested approximately $613,000 in Oscar Health, acquiring 46,791 shares of the company in the first quarter.
• Several institutional investors have also adjusted their stakes in Oscar Health, with 75.70% of the stock now owned by institutional holders.
• Analysts have downgraded Oscar Health's stock, with multiple price targets being lowered, setting the current consensus target at $12.21.

XTX Topco Ltd acquired a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 46,791 shares of the company's stock, valued at approximately $613,000.

Several other large investors have also made changes to their positions in OSCR. Deerfield Management Company L.P. Series C boosted its holdings in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock valued at $159,062,000 after acquiring an additional 3,983,325 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its holdings in shares of Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. Thrive Capital Management LLC boosted its holdings in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Man Group plc boosted its holdings in shares of Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after acquiring an additional 1,405,554 shares during the last quarter. Finally, Ancient Art L.P. boosted its holdings in shares of Oscar Health by 66.8% in the 4th quarter. Ancient Art L.P. now owns 2,950,753 shares of the company's stock valued at $39,658,000 after acquiring an additional 1,182,134 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Trading Up 1.8%

Shares of OSCR traded up $0.27 during mid-day trading on Friday, reaching $15.43. The stock had a trading volume of 16,244,433 shares, compared to its average volume of 35,176,252. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The business's fifty day moving average is $15.90 and its 200 day moving average is $14.86. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of -19.05 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.75%. The firm had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the prior year, the firm posted $0.20 earnings per share. Oscar Health's quarterly revenue was up 29.0% on a year-over-year basis. On average, sell-side analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on OSCR. UBS Group reissued a "sell" rating and set a $11.00 price target (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Robert W. Baird reissued a "neutral" rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. Piper Sandler downgraded shares of Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price target on the stock. in a report on Monday, July 14th. Finally, Barclays lowered their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a report on Wednesday, July 23rd. Six research analysts have rated the stock with a sell rating and four have issued a hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Reduce" and an average price target of $12.21.

Insider Activity

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 24.39% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.